Propentofylline: Discontinued Phase IIIB study development

By WIR Staff | Mar 6, 2000 | 8:00 AM GMT

Aventis Pharma AG (AVE; NM:AVE; DAX:AVE), Frankfurt, Germany

Read the full 81 word article

How to gain access

Continue reading with a
two-week free trial.